

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of norepinephrine secretion (GO:0010700) | 9.13605153 |
| 2 | regulation of gonadotropin secretion (GO:0032276) | 8.63328395 |
| 3 | phenylpropanoid metabolic process (GO:0009698) | 7.87939832 |
| 4 | glucocorticoid biosynthetic process (GO:0006704) | 7.74943741 |
| 5 | positive regulation of digestive system process (GO:0060456) | 7.25192039 |
| 6 | parturition (GO:0007567) | 6.99968549 |
| 7 | locomotory exploration behavior (GO:0035641) | 6.88650828 |
| 8 | positive regulation of odontogenesis (GO:0042482) | 6.85054475 |
| 9 | positive regulation of steroid hormone secretion (GO:2000833) | 6.79642767 |
| 10 | tooth mineralization (GO:0034505) | 6.78608890 |
| 11 | regulation of glucocorticoid secretion (GO:2000849) | 6.69117750 |
| 12 | regulation of corticosteroid hormone secretion (GO:2000846) | 6.55872046 |
| 13 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 5.79457433 |
| 14 | negative regulation of catecholamine secretion (GO:0033604) | 5.72257281 |
| 15 | * positive regulation of calcium ion import (GO:0090280) | 5.62740694 |
| 16 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 5.44767209 |
| 17 | regulation of monocyte differentiation (GO:0045655) | 5.31486196 |
| 18 | cellular response to dexamethasone stimulus (GO:0071549) | 5.11218469 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 4.92827329 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.92827329 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.84420978 |
| 22 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 4.83808783 |
| 23 | hypothalamus development (GO:0021854) | 4.82558403 |
| 24 | protein carboxylation (GO:0018214) | 4.79974081 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.79974081 |
| 26 | L-phenylalanine metabolic process (GO:0006558) | 4.78227402 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.78227402 |
| 28 | response to dexamethasone (GO:0071548) | 4.74660984 |
| 29 | negative regulation of circadian rhythm (GO:0042754) | 4.74068685 |
| 30 | RNA destabilization (GO:0050779) | 4.74068385 |
| 31 | synaptic transmission, dopaminergic (GO:0001963) | 4.72795709 |
| 32 | epoxygenase P450 pathway (GO:0019373) | 4.66178747 |
| 33 | regulation of steroid hormone secretion (GO:2000831) | 4.62556721 |
| 34 | ether metabolic process (GO:0018904) | 4.57693826 |
| 35 | glucocorticoid metabolic process (GO:0008211) | 4.54126290 |
| 36 | regulation of norepinephrine secretion (GO:0014061) | 4.52549149 |
| 37 | regulation of fibrinolysis (GO:0051917) | 4.46600058 |
| 38 | aromatic amino acid family catabolic process (GO:0009074) | 4.34163043 |
| 39 | somite development (GO:0061053) | 4.29366695 |
| 40 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.27402789 |
| 41 | regulation of protein activation cascade (GO:2000257) | 4.24958178 |
| 42 | convergent extension (GO:0060026) | 4.23894541 |
| 43 | protein heterotrimerization (GO:0070208) | 4.23673486 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.20391417 |
| 45 | alpha-linolenic acid metabolic process (GO:0036109) | 4.18875979 |
| 46 | circadian sleep/wake cycle process (GO:0022410) | 4.18162148 |
| 47 | adrenal gland development (GO:0030325) | 4.14359343 |
| 48 | regulation of complement activation (GO:0030449) | 4.09681065 |
| 49 | glyoxylate metabolic process (GO:0046487) | 4.05171342 |
| 50 | complement activation, alternative pathway (GO:0006957) | 3.94115825 |
| 51 | kynurenine metabolic process (GO:0070189) | 3.93362935 |
| 52 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.92815443 |
| 53 | bile acid biosynthetic process (GO:0006699) | 3.90903565 |
| 54 | homocysteine metabolic process (GO:0050667) | 3.82377393 |
| 55 | regulation of circadian sleep/wake cycle (GO:0042749) | 3.82081556 |
| 56 | regulation of circadian sleep/wake cycle, sleep (GO:0045187) | 3.82081556 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 3.81878995 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 3.81878995 |
| 59 | tryptophan catabolic process (GO:0006569) | 3.81878995 |
| 60 | glutathione biosynthetic process (GO:0006750) | 3.76662904 |
| 61 | cellular response to ammonium ion (GO:0071242) | 3.75957073 |
| 62 | lysine catabolic process (GO:0006554) | 3.75686224 |
| 63 | lysine metabolic process (GO:0006553) | 3.75686224 |
| 64 | response to corticosterone (GO:0051412) | 3.73010916 |
| 65 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.69143387 |
| 66 | positive regulation of circadian rhythm (GO:0042753) | 3.68544014 |
| 67 | sulfur amino acid catabolic process (GO:0000098) | 3.64997785 |
| 68 | tryptophan metabolic process (GO:0006568) | 3.60417096 |
| 69 | exploration behavior (GO:0035640) | 3.55563673 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53128222 |
| 71 | response to mineralocorticoid (GO:0051385) | 3.52649673 |
| 72 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.51923919 |
| 73 | L-serine transport (GO:0015825) | 3.51505014 |
| 74 | fibrinolysis (GO:0042730) | 3.49896024 |
| 75 | toxin metabolic process (GO:0009404) | 3.48750845 |
| 76 | negative regulation of gluconeogenesis (GO:0045721) | 3.47601876 |
| 77 | cysteine metabolic process (GO:0006534) | 3.43824859 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 3.42408319 |
| 79 | * regulation of calcium ion import (GO:0090279) | 3.39418541 |
| 80 | regulation of triglyceride catabolic process (GO:0010896) | 3.38009683 |
| 81 | urea metabolic process (GO:0019627) | 3.37671538 |
| 82 | urea cycle (GO:0000050) | 3.37671538 |
| 83 | collagen fibril organization (GO:0030199) | 3.37479210 |
| 84 | regulation of plasminogen activation (GO:0010755) | 3.35498141 |
| 85 | positive regulation of macrophage differentiation (GO:0045651) | 3.33535385 |
| 86 | amino-acid betaine metabolic process (GO:0006577) | 3.33344702 |
| 87 | negative regulation of cartilage development (GO:0061037) | 3.30380795 |
| 88 | cellular response to ketone (GO:1901655) | 3.29197484 |
| 89 | positive regulation of fatty acid oxidation (GO:0046321) | 3.28368096 |
| 90 | plasma lipoprotein particle clearance (GO:0034381) | 3.25698032 |
| 91 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.24845303 |
| 92 | bile acid metabolic process (GO:0008206) | 3.24064817 |
| 93 | regulation of cholesterol homeostasis (GO:2000188) | 3.22867285 |
| 94 | circadian behavior (GO:0048512) | 3.19358463 |
| 95 | cochlea morphogenesis (GO:0090103) | 3.18336374 |
| 96 | barbed-end actin filament capping (GO:0051016) | 3.17776446 |
| 97 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.16526261 |
| 98 | triglyceride homeostasis (GO:0070328) | 3.16079136 |
| 99 | acylglycerol homeostasis (GO:0055090) | 3.16079136 |
| 100 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.12176740 |
| 101 | nitrogen cycle metabolic process (GO:0071941) | 3.12116494 |
| 102 | response to gravity (GO:0009629) | 3.11410022 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 3.10147571 |
| 104 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.09594073 |
| 105 | negative regulation of protein activation cascade (GO:2000258) | 3.08887995 |
| 106 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.08228664 |
| 107 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.06925151 |
| 108 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.06925151 |
| 109 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.06925151 |
| 110 | keratan sulfate catabolic process (GO:0042340) | 3.04819692 |
| 111 | serine family amino acid catabolic process (GO:0009071) | 3.04641041 |
| 112 | reverse cholesterol transport (GO:0043691) | 3.03317913 |
| 113 | cellular ketone body metabolic process (GO:0046950) | 3.02516386 |
| 114 | tyrosine metabolic process (GO:0006570) | 3.02069345 |
| 115 | omega-hydroxylase P450 pathway (GO:0097267) | 3.01873126 |
| 116 | alpha-amino acid catabolic process (GO:1901606) | 2.99897516 |
| 117 | aromatic amino acid family metabolic process (GO:0009072) | 2.99880138 |
| 118 | chronic inflammatory response (GO:0002544) | 2.97859219 |
| 119 | extracellular matrix assembly (GO:0085029) | 2.97130449 |
| 120 | regulation of mononuclear cell migration (GO:0071675) | 2.96394782 |
| 121 | negative regulation of amine transport (GO:0051953) | 2.96324342 |
| 122 | opsonization (GO:0008228) | 2.94891153 |
| 123 | protein-lipid complex remodeling (GO:0034368) | 2.93894140 |
| 124 | macromolecular complex remodeling (GO:0034367) | 2.93894140 |
| 125 | plasma lipoprotein particle remodeling (GO:0034369) | 2.93894140 |
| 126 | serine transport (GO:0032329) | 2.93046277 |
| 127 | rhythmic behavior (GO:0007622) | 2.92920203 |
| 128 | virion attachment to host cell (GO:0019062) | 2.92695941 |
| 129 | adhesion of symbiont to host cell (GO:0044650) | 2.92695941 |
| 130 | skin morphogenesis (GO:0043589) | 2.91244014 |
| 131 | fatty acid beta-oxidation (GO:0006635) | 2.90004331 |
| 132 | 2-oxoglutarate metabolic process (GO:0006103) | 2.89399184 |
| 133 | cellular modified amino acid catabolic process (GO:0042219) | 2.89247650 |
| 134 | coenzyme catabolic process (GO:0009109) | 2.89182288 |
| 135 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.88591840 |
| 136 | chondrocyte proliferation (GO:0035988) | 2.85815208 |
| 137 | cellular glucuronidation (GO:0052695) | 2.85667345 |
| 138 | negative regulation of cholesterol transport (GO:0032375) | 2.85439579 |
| 139 | negative regulation of sterol transport (GO:0032372) | 2.85439579 |
| 140 | glutamate metabolic process (GO:0006536) | 2.85059737 |
| 141 | regulation of sequestering of triglyceride (GO:0010889) | 2.84009085 |
| 142 | extracellular fibril organization (GO:0043206) | 2.83832614 |
| 143 | regulation of cholesterol esterification (GO:0010872) | 2.82665989 |
| 144 | negative regulation of blood coagulation (GO:0030195) | 2.81680463 |
| 145 | negative regulation of hemostasis (GO:1900047) | 2.81680463 |
| 146 | leukotriene biosynthetic process (GO:0019370) | 2.81468300 |
| 147 | fatty acid oxidation (GO:0019395) | 2.81396488 |
| 148 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.80920255 |
| 149 | cell proliferation involved in kidney development (GO:0072111) | 2.80825872 |
| 150 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.80670726 |
| 151 | embryonic process involved in female pregnancy (GO:0060136) | 2.79161886 |
| 152 | ethanol oxidation (GO:0006069) | 2.79014051 |
| 153 | cell proliferation involved in metanephros development (GO:0072203) | 2.78993122 |
| 154 | metanephric mesenchyme development (GO:0072075) | 2.78812415 |
| 155 | venous blood vessel morphogenesis (GO:0048845) | 2.78164532 |
| 156 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.78029502 |
| 157 | cellular amino acid catabolic process (GO:0009063) | 2.77857083 |
| 158 | negative regulation of lipase activity (GO:0060192) | 2.77694088 |
| 159 | cell migration involved in heart development (GO:0060973) | 2.75497526 |
| 160 | bile acid and bile salt transport (GO:0015721) | 2.75290319 |
| 161 | acetyl-CoA metabolic process (GO:0006084) | 2.75226052 |
| 162 | kidney mesenchyme development (GO:0072074) | 2.75209954 |
| 163 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.74822062 |
| 164 | lipid oxidation (GO:0034440) | 2.74457051 |
| 165 | midgut development (GO:0007494) | 2.72808302 |
| 166 | phospholipid efflux (GO:0033700) | 2.70610741 |
| 167 | aspartate family amino acid catabolic process (GO:0009068) | 2.70455755 |
| 168 | positive regulation of hemostasis (GO:1900048) | 2.70321975 |
| 169 | positive regulation of blood coagulation (GO:0030194) | 2.70321975 |
| 170 | fatty acid transmembrane transport (GO:1902001) | 2.69303025 |
| 171 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.69027307 |
| 172 | response to mercury ion (GO:0046689) | 2.68499706 |
| 173 | lymph vessel development (GO:0001945) | 2.68401080 |
| 174 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.68017889 |
| 175 | carnitine metabolic process (GO:0009437) | 2.67294152 |
| 176 | short-chain fatty acid metabolic process (GO:0046459) | 2.65898940 |
| 177 | basement membrane organization (GO:0071711) | 2.65871786 |
| 178 | fatty acid catabolic process (GO:0009062) | 2.65797661 |
| 179 | peptide biosynthetic process (GO:0043043) | 2.64596222 |
| 180 | regulation of odontogenesis (GO:0042481) | 2.63754908 |
| 181 | type B pancreatic cell proliferation (GO:0044342) | 2.62682908 |
| 182 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.60804472 |
| 183 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.59928994 |
| 184 | vasculature development (GO:0001944) | 2.56726519 |
| 185 | protein retention in ER lumen (GO:0006621) | 2.56052611 |
| 186 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.55484215 |
| 187 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.55291090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.30543759 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.17405080 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.66504652 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.39668819 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.36277509 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.77198221 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.34160172 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.30828202 |
| 9 | * CLOCK_20551151_ChIP-Seq_293T_Human | 3.26239761 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.15491906 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.06468070 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.01771220 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.66110063 |
| 14 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.26106667 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.18069644 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.17375885 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.14299013 |
| 18 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.07112749 |
| 19 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.06753876 |
| 20 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.06753876 |
| 21 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.06753876 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.97864615 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95936681 |
| 24 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.87137805 |
| 25 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.82315708 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79562044 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.72530085 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70556754 |
| 29 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.67116628 |
| 30 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.65091209 |
| 31 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.64859998 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.64859998 |
| 33 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.59422596 |
| 34 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58417020 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57071352 |
| 36 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.56859759 |
| 37 | CJUN_26792858_Chip-Seq_BT549_Human | 1.53278809 |
| 38 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.52227764 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50167321 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.49105443 |
| 41 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.48955139 |
| 42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47279083 |
| 43 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.42112527 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.37016531 |
| 45 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.36923087 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.34298016 |
| 47 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.34200387 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33041879 |
| 49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30081038 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30044546 |
| 51 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29601181 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29601181 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24377777 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23700331 |
| 55 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23362363 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.20488261 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20460789 |
| 58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16744357 |
| 59 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.16396756 |
| 60 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14303805 |
| 61 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09264308 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07344352 |
| 63 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.06333994 |
| 64 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.05618387 |
| 65 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05288178 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.05164484 |
| 67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03197973 |
| 68 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03028420 |
| 69 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.02724402 |
| 70 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02490204 |
| 71 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01552105 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00472342 |
| 73 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.00247803 |
| 74 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00078420 |
| 75 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97830160 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97393831 |
| 77 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.96790290 |
| 78 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94847283 |
| 79 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.93829338 |
| 80 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.93829338 |
| 81 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93373676 |
| 82 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93258278 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93174348 |
| 84 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91926095 |
| 85 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.91619330 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90570890 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89129281 |
| 88 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88702511 |
| 89 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88556028 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88554093 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.87778665 |
| 92 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86790352 |
| 93 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.86625364 |
| 94 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84635377 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.83753485 |
| 96 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.83207158 |
| 97 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.82713432 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82267801 |
| 99 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.81906988 |
| 100 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81004286 |
| 101 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.80860472 |
| 102 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.79996992 |
| 103 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.78872302 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78844336 |
| 105 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.78708750 |
| 106 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.78153358 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.77727318 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77232864 |
| 109 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.77014793 |
| 110 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.76786226 |
| 111 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.76554680 |
| 112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76496154 |
| 113 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76410132 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76154583 |
| 115 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76067850 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.75281670 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.75160733 |
| 118 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.75121259 |
| 119 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.74855964 |
| 120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74478710 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74453006 |
| 122 | * PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.74323708 |
| 123 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73888067 |
| 124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73888067 |
| 125 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.73814790 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73425543 |
| 127 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.73361355 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.72676684 |
| 129 | RXR_22108803_ChIP-Seq_LS180_Human | 0.71922407 |
| 130 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.71698764 |
| 131 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71176884 |
| 132 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.70114974 |
| 133 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.69468167 |
| 134 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69226828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.36414028 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.51598121 |
| 3 | MP0005360_urolithiasis | 4.43188077 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.92317216 |
| 5 | MP0004782_abnormal_surfactant_physiolog | 3.65665481 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.65642073 |
| 7 | MP0005365_abnormal_bile_salt | 3.50865388 |
| 8 | MP0005503_abnormal_tendon_morphology | 3.17179277 |
| 9 | MP0005275_abnormal_skin_tensile | 3.16560019 |
| 10 | MP0003279_aneurysm | 3.06594155 |
| 11 | MP0004272_abnormal_basement_membrane | 2.82817553 |
| 12 | MP0003252_abnormal_bile_duct | 2.80544209 |
| 13 | MP0003329_amyloid_beta_deposits | 2.70457594 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.63783112 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.41220256 |
| 16 | MP0009384_cardiac_valve_regurgitation | 2.29960410 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.20321578 |
| 18 | MP0001958_emphysema | 2.15224064 |
| 19 | MP0004858_abnormal_nervous_system | 2.01829761 |
| 20 | MP0002933_joint_inflammation | 1.98251830 |
| 21 | MP0006054_spinal_hemorrhage | 1.89032554 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.87101662 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.82517092 |
| 24 | MP0002998_abnormal_bone_remodeling | 1.74453400 |
| 25 | MP0002295_abnormal_pulmonary_circulatio | 1.67028158 |
| 26 | MP0000604_amyloidosis | 1.66909690 |
| 27 | MP0005623_abnormal_meninges_morphology | 1.66497615 |
| 28 | MP0005647_abnormal_sex_gland | 1.65938136 |
| 29 | MP0005083_abnormal_biliary_tract | 1.63538038 |
| 30 | MP0005332_abnormal_amino_acid | 1.60629872 |
| 31 | MP0003195_calcinosis | 1.59865655 |
| 32 | MP0001879_abnormal_lymphatic_vessel | 1.58242867 |
| 33 | MP0001851_eye_inflammation | 1.55103372 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.52142344 |
| 35 | MP0000767_abnormal_smooth_muscle | 1.50547807 |
| 36 | MP0000681_abnormal_thyroid_gland | 1.49987329 |
| 37 | MP0009840_abnormal_foam_cell | 1.49769340 |
| 38 | MP0005187_abnormal_penis_morphology | 1.49371989 |
| 39 | MP0005023_abnormal_wound_healing | 1.45709311 |
| 40 | MP0001853_heart_inflammation | 1.45219065 |
| 41 | MP0002108_abnormal_muscle_morphology | 1.44049934 |
| 42 | MP0002060_abnormal_skin_morphology | 1.37082757 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.32999213 |
| 44 | MP0000343_altered_response_to | 1.28091741 |
| 45 | MP0001542_abnormal_bone_strength | 1.27727268 |
| 46 | MP0003091_abnormal_cell_migration | 1.26249488 |
| 47 | MP0005508_abnormal_skeleton_morphology | 1.24692089 |
| 48 | * MP0009278_abnormal_bone_marrow | 1.24663502 |
| 49 | MP0000751_myopathy | 1.22097959 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.21935430 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.20731977 |
| 52 | MP0005595_abnormal_vascular_smooth | 1.20535864 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.19574354 |
| 54 | MP0004130_abnormal_muscle_cell | 1.18470480 |
| 55 | MP0000609_abnormal_liver_physiology | 1.17838500 |
| 56 | MP0002896_abnormal_bone_mineralization | 1.17443279 |
| 57 | MP0001727_abnormal_embryo_implantation | 1.15532368 |
| 58 | MP0000639_abnormal_adrenal_gland | 1.14763706 |
| 59 | MP0005330_cardiomyopathy | 1.13495872 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.11727183 |
| 61 | MP0005670_abnormal_white_adipose | 1.10391249 |
| 62 | MP0003566_abnormal_cell_adhesion | 1.09272520 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.08718079 |
| 64 | MP0003795_abnormal_bone_structure | 1.07425571 |
| 65 | MP0001881_abnormal_mammary_gland | 1.06648253 |
| 66 | MP0005257_abnormal_intraocular_pressure | 1.05165511 |
| 67 | MP0005165_increased_susceptibility_to | 1.04121084 |
| 68 | MP0006138_congestive_heart_failure | 1.04069671 |
| 69 | MP0005084_abnormal_gallbladder_morpholo | 1.03927699 |
| 70 | MP0003300_gastrointestinal_ulcer | 1.02866466 |
| 71 | MP0003959_abnormal_lean_body | 1.02431640 |
| 72 | MP0004947_skin_inflammation | 0.99760833 |
| 73 | MP0001502_abnormal_circadian_rhythm | 0.99522745 |
| 74 | * MP0002128_abnormal_blood_circulation | 0.99395941 |
| 75 | MP0000759_abnormal_skeletal_muscle | 0.99170755 |
| 76 | MP0005666_abnormal_adipose_tissue | 0.98790714 |
| 77 | MP0005164_abnormal_response_to | 0.98788943 |
| 78 | MP0003724_increased_susceptibility_to | 0.98561398 |
| 79 | MP0005388_respiratory_system_phenotype | 0.96363097 |
| 80 | MP0002133_abnormal_respiratory_system | 0.96363097 |
| 81 | MP0001243_abnormal_dermal_layer | 0.96193497 |
| 82 | MP0002127_abnormal_cardiovascular_syste | 0.96100117 |
| 83 | MP0005369_muscle_phenotype | 0.92508373 |
| 84 | MP0008775_abnormal_heart_ventricle | 0.91495546 |
| 85 | MP0009379_abnormal_foot_pigmentation | 0.90347891 |
| 86 | MP0003385_abnormal_body_wall | 0.89322502 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.89043900 |
| 88 | MP0005375_adipose_tissue_phenotype | 0.87914519 |
| 89 | MP0004883_abnormal_blood_vessel | 0.87713597 |
| 90 | MP0004084_abnormal_cardiac_muscle | 0.87217289 |
| 91 | MP0002138_abnormal_hepatobiliary_system | 0.85610410 |
| 92 | MP0006276_abnormal_autonomic_nervous | 0.83245300 |
| 93 | MP0002254_reproductive_system_inflammat | 0.83043229 |
| 94 | MP0004019_abnormal_vitamin_homeostasis | 0.82936369 |
| 95 | MP0003115_abnormal_respiratory_system | 0.82863183 |
| 96 | MP0000249_abnormal_blood_vessel | 0.82716080 |
| 97 | MP0003632_abnormal_nervous_system | 0.82202259 |
| 98 | MP0003950_abnormal_plasma_membrane | 0.81598222 |
| 99 | MP0003718_maternal_effect | 0.80977981 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.80770680 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.78740885 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 0.78680882 |
| 103 | MP0005385_cardiovascular_system_phenoty | 0.78680882 |
| 104 | MP0001661_extended_life_span | 0.78537320 |
| 105 | MP0005171_absent_coat_pigmentation | 0.77708176 |
| 106 | MP0002168_other_aberrant_phenotype | 0.77537929 |
| 107 | MP0001756_abnormal_urination | 0.77283398 |
| 108 | * MP0000598_abnormal_liver_morphology | 0.77161076 |
| 109 | MP0001915_intracranial_hemorrhage | 0.76167518 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.75199492 |
| 111 | MP0005620_abnormal_muscle_contractility | 0.74831351 |
| 112 | MP0001849_ear_inflammation | 0.74592709 |
| 113 | MP0004087_abnormal_muscle_fiber | 0.74444095 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.73790104 |
| 115 | MP0002249_abnormal_larynx_morphology | 0.73719522 |
| 116 | MP0009053_abnormal_anal_canal | 0.72719436 |
| 117 | * MP0001614_abnormal_blood_vessel | 0.71684833 |
| 118 | MP0002113_abnormal_skeleton_development | 0.71522701 |
| 119 | MP0002928_abnormal_bile_duct | 0.71145610 |
| 120 | MP0002115_abnormal_skeleton_extremities | 0.68190636 |
| 121 | MP0009764_decreased_sensitivity_to | 0.68134364 |
| 122 | MP0000733_abnormal_muscle_development | 0.67634007 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67563022 |
| 124 | MP0009250_abnormal_appendicular_skeleto | 0.66829508 |
| 125 | MP0004147_increased_porphyrin_level | 0.66584420 |
| 126 | MP0005220_abnormal_exocrine_pancreas | 0.66259133 |
| 127 | MP0003868_abnormal_feces_composition | 0.65072955 |
| 128 | * MP0001545_abnormal_hematopoietic_system | 0.64417104 |
| 129 | * MP0005397_hematopoietic_system_phenotyp | 0.64417104 |
| 130 | MP0000049_abnormal_middle_ear | 0.64104940 |
| 131 | MP0000163_abnormal_cartilage_morphology | 0.63782064 |
| 132 | MP0004036_abnormal_muscle_relaxation | 0.63077040 |
| 133 | MP0003303_peritoneal_inflammation | 0.62878042 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.62855264 |
| 135 | MP0009763_increased_sensitivity_to | 0.62388182 |
| 136 | MP0003690_abnormal_glial_cell | 0.62023285 |
| 137 | MP0000747_muscle_weakness | 0.61587385 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.61559919 |
| 139 | MP0002971_abnormal_brown_adipose | 0.61201265 |
| 140 | MP0000534_abnormal_ureter_morphology | 0.60888310 |
| 141 | MP0005390_skeleton_phenotype | 0.60313788 |
| 142 | MP0008874_decreased_physiological_sensi | 0.59827429 |
| 143 | MP0009785_altered_susceptibility_to | 0.59766172 |
| 144 | MP0000432_abnormal_head_morphology | 0.59539101 |
| 145 | MP0010030_abnormal_orbit_morphology | 0.59468366 |
| 146 | MP0000858_altered_metastatic_potential | 0.59388829 |
| 147 | MP0004510_myositis | 0.59100039 |
| 148 | MP0004233_abnormal_muscle_weight | 0.57840815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Arterial tortuosity (HP:0005116) | 7.33967524 |
| 2 | Protrusio acetabuli (HP:0003179) | 6.56732319 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.39647174 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.18027269 |
| 5 | Metaphyseal cupping (HP:0003021) | 4.28939488 |
| 6 | Osteomalacia (HP:0002749) | 4.20671824 |
| 7 | Broad metatarsal (HP:0001783) | 4.19400722 |
| 8 | Ankle contracture (HP:0006466) | 4.17337460 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 4.01558151 |
| 10 | Xanthomatosis (HP:0000991) | 3.97020615 |
| 11 | Pulmonary artery stenosis (HP:0004415) | 3.92268720 |
| 12 | Widely patent fontanelles and sutures (HP:0004492) | 3.91552201 |
| 13 | Aortic regurgitation (HP:0001659) | 3.82065920 |
| 14 | Aortic aneurysm (HP:0004942) | 3.77932831 |
| 15 | Aortic dissection (HP:0002647) | 3.75467799 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.74642744 |
| 17 | Peritonitis (HP:0002586) | 3.70971544 |
| 18 | Abnormality of the costochondral junction (HP:0000919) | 3.66587714 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.64580786 |
| 20 | Polyphagia (HP:0002591) | 3.59074374 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.56431676 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 3.43085287 |
| 23 | Complement deficiency (HP:0004431) | 3.31977184 |
| 24 | Papilledema (HP:0001085) | 3.26103247 |
| 25 | Wide cranial sutures (HP:0010537) | 3.19610019 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.16618313 |
| 27 | Aortic valve stenosis (HP:0001650) | 3.10926194 |
| 28 | Cerebral aneurysm (HP:0004944) | 3.07457969 |
| 29 | Abnormal vertebral ossification (HP:0100569) | 3.06807643 |
| 30 | Abnormality of skull ossification (HP:0002703) | 3.06797978 |
| 31 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03561741 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 3.02683945 |
| 33 | Nonimmune hydrops fetalis (HP:0001790) | 3.01552909 |
| 34 | Asymmetric septal hypertrophy (HP:0001670) | 2.99672378 |
| 35 | Type 1 muscle fiber predominance (HP:0003803) | 2.98442914 |
| 36 | Follicular hyperkeratosis (HP:0007502) | 2.93645886 |
| 37 | Hypoglycemic coma (HP:0001325) | 2.90987352 |
| 38 | Bladder diverticulum (HP:0000015) | 2.89234152 |
| 39 | Biconcave vertebral bodies (HP:0004586) | 2.88873880 |
| 40 | Soft skin (HP:0000977) | 2.88013988 |
| 41 | Hypobetalipoproteinemia (HP:0003563) | 2.86205848 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.82080168 |
| 43 | Premature loss of primary teeth (HP:0006323) | 2.81231584 |
| 44 | Shallow orbits (HP:0000586) | 2.76609211 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.76272856 |
| 46 | Atrophic scars (HP:0001075) | 2.71843002 |
| 47 | Ketosis (HP:0001946) | 2.71517974 |
| 48 | Increased connective tissue (HP:0009025) | 2.70468519 |
| 49 | Growth hormone deficiency (HP:0000824) | 2.70228090 |
| 50 | Joint stiffness (HP:0001387) | 2.70134437 |
| 51 | Neonatal short-limb short stature (HP:0008921) | 2.68126239 |
| 52 | Mitral valve prolapse (HP:0001634) | 2.66758251 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.65360532 |
| 54 | Hyperammonemia (HP:0001987) | 2.62148488 |
| 55 | Spinal rigidity (HP:0003306) | 2.60210899 |
| 56 | Dilatation of the ascending aorta (HP:0005111) | 2.59004068 |
| 57 | Mitral stenosis (HP:0001718) | 2.56900929 |
| 58 | Increased corneal curvature (HP:0100692) | 2.56344046 |
| 59 | Keratoconus (HP:0000563) | 2.56344046 |
| 60 | Blue sclerae (HP:0000592) | 2.55398890 |
| 61 | Skin nodule (HP:0200036) | 2.54912365 |
| 62 | Joint hemorrhage (HP:0005261) | 2.54424723 |
| 63 | Abnormality of complement system (HP:0005339) | 2.53895338 |
| 64 | Myocardial infarction (HP:0001658) | 2.53203015 |
| 65 | Cardiovascular calcification (HP:0011915) | 2.53021169 |
| 66 | Abnormality of dentin (HP:0010299) | 2.51971564 |
| 67 | Decreased skull ossification (HP:0004331) | 2.51524592 |
| 68 | Aneurysm (HP:0002617) | 2.50535104 |
| 69 | Epidermoid cyst (HP:0200040) | 2.45083535 |
| 70 | Chondrocalcinosis (HP:0000934) | 2.44174242 |
| 71 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42676697 |
| 72 | Cervical subluxation (HP:0003308) | 2.41859691 |
| 73 | Abnormal delivery (HP:0001787) | 2.40468988 |
| 74 | Ectopia lentis (HP:0001083) | 2.40246744 |
| 75 | Turricephaly (HP:0000262) | 2.39356298 |
| 76 | Axonal loss (HP:0003447) | 2.36919895 |
| 77 | Joint laxity (HP:0001388) | 2.36878028 |
| 78 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.36854733 |
| 79 | Spondylolisthesis (HP:0003302) | 2.34103989 |
| 80 | Vertebral clefting (HP:0008428) | 2.31572134 |
| 81 | Abnormality of Sharpey fibers (HP:0100685) | 2.29670189 |
| 82 | Lymphangioma (HP:0100764) | 2.25590001 |
| 83 | Abnormality of the diencephalon (HP:0010662) | 2.25583245 |
| 84 | Ketoacidosis (HP:0001993) | 2.25275382 |
| 85 | Wormian bones (HP:0002645) | 2.25208984 |
| 86 | Vascular tortuosity (HP:0004948) | 2.23763435 |
| 87 | Vertebral compression fractures (HP:0002953) | 2.23507405 |
| 88 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.22734243 |
| 89 | Thin skin (HP:0000963) | 2.21377200 |
| 90 | Malnutrition (HP:0004395) | 2.19485737 |
| 91 | Esophageal varix (HP:0002040) | 2.19119035 |
| 92 | Hyperglycinemia (HP:0002154) | 2.18779078 |
| 93 | Infantile muscular hypotonia (HP:0008947) | 2.18451790 |
| 94 | Fragile skin (HP:0001030) | 2.18264422 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17449578 |
| 96 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.16476704 |
| 97 | Abnormality of glycine metabolism (HP:0010895) | 2.16476704 |
| 98 | Abnormal cartilage morphology (HP:0002763) | 2.14996415 |
| 99 | Delayed CNS myelination (HP:0002188) | 2.14769098 |
| 100 | Slender build (HP:0001533) | 2.14366777 |
| 101 | Stroke (HP:0001297) | 2.13780312 |
| 102 | Osteolytic defects of the hand bones (HP:0009699) | 2.12196839 |
| 103 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.12196839 |
| 104 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11629986 |
| 105 | Wide anterior fontanel (HP:0000260) | 2.11531624 |
| 106 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11130214 |
| 107 | Spontaneous hematomas (HP:0007420) | 2.09867094 |
| 108 | Vascular calcification (HP:0004934) | 2.09639436 |
| 109 | Overgrowth (HP:0001548) | 2.07192758 |
| 110 | Hypercholesterolemia (HP:0003124) | 2.06535029 |
| 111 | Wrist flexion contracture (HP:0001239) | 2.06388055 |
| 112 | Short nail (HP:0001799) | 2.05502121 |
| 113 | Hyperglycinuria (HP:0003108) | 2.05207259 |
| 114 | Fat malabsorption (HP:0002630) | 2.05109030 |
| 115 | Abnormality of methionine metabolism (HP:0010901) | 2.05050299 |
| 116 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.03954349 |
| 117 | Right ventricular cardiomyopathy (HP:0011663) | 2.02892469 |
| 118 | Hepatocellular carcinoma (HP:0001402) | 2.02739172 |
| 119 | Hemorrhage of the eye (HP:0011885) | 2.01093906 |
| 120 | Bell-shaped thorax (HP:0001591) | 1.99880409 |
| 121 | Abnormality of proline metabolism (HP:0010907) | 1.99663911 |
| 122 | Hydroxyprolinuria (HP:0003080) | 1.99663911 |
| 123 | Hypercalcemia (HP:0003072) | 1.98441640 |
| 124 | Short hallux (HP:0010109) | 1.96654910 |
| 125 | Venous insufficiency (HP:0005293) | 1.94892377 |
| 126 | Ulnar bowing (HP:0003031) | 1.93948747 |
| 127 | Hyperextensible skin (HP:0000974) | 1.92604304 |
| 128 | Bone cyst (HP:0012062) | 1.91646327 |
| 129 | Hypoplasia of the iris (HP:0007676) | 1.91412772 |
| 130 | Abnormal eating behavior (HP:0100738) | 1.90934303 |
| 131 | Dysostosis multiplex (HP:0000943) | 1.89629933 |
| 132 | Venous abnormality (HP:0002624) | 1.89019830 |
| 133 | Polycythemia (HP:0001901) | 1.88235464 |
| 134 | Ovoid vertebral bodies (HP:0003300) | 1.87813393 |
| 135 | Metaphyseal dysplasia (HP:0100255) | 1.83700435 |
| 136 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.83331925 |
| 137 | Abnormality of the Achilles tendon (HP:0005109) | 1.82582660 |
| 138 | Generalized amyotrophy (HP:0003700) | 1.80615464 |
| 139 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.79649923 |
| 140 | Camptodactyly of toe (HP:0001836) | 1.79257233 |
| 141 | Ileus (HP:0002595) | 1.77484503 |
| 142 | Elbow flexion contracture (HP:0002987) | 1.76971714 |
| 143 | Bowel diverticulosis (HP:0005222) | 1.76780840 |
| 144 | Genu recurvatum (HP:0002816) | 1.76257314 |
| 145 | Round ear (HP:0100830) | 1.75078874 |
| 146 | Spontaneous abortion (HP:0005268) | 1.74441811 |
| 147 | Mesangial abnormality (HP:0001966) | 1.73987999 |
| 148 | Abnormality of primary teeth (HP:0006481) | 1.72949863 |
| 149 | Long toe (HP:0010511) | 1.71907161 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.69547009 |
| 151 | Mucopolysacchariduria (HP:0008155) | 1.69547009 |
| 152 | Pathologic fracture (HP:0002756) | 1.68511294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDGFRA | 3.95704327 |
| 2 | TTN | 3.81989096 |
| 3 | ERN1 | 3.48988347 |
| 4 | TRIB3 | 3.19166462 |
| 5 | DDR2 | 3.15612647 |
| 6 | SIK1 | 3.12882621 |
| 7 | MYLK | 3.12785517 |
| 8 | TIE1 | 3.06817072 |
| 9 | KDR | 2.98795451 |
| 10 | MOS | 2.81283651 |
| 11 | BCKDK | 2.52707913 |
| 12 | PKN2 | 2.50677290 |
| 13 | LATS1 | 2.36280363 |
| 14 | GRK7 | 2.29792349 |
| 15 | FGFR4 | 2.29714878 |
| 16 | GRK5 | 2.26746915 |
| 17 | EPHB2 | 2.13961678 |
| 18 | INSRR | 2.06048792 |
| 19 | RIPK1 | 1.94071972 |
| 20 | KIT | 1.74097774 |
| 21 | TESK1 | 1.71006444 |
| 22 | MAPK4 | 1.63638095 |
| 23 | TGFBR2 | 1.61932964 |
| 24 | DMPK | 1.59470590 |
| 25 | FGFR2 | 1.55044723 |
| 26 | PTK6 | 1.54201735 |
| 27 | PAK2 | 1.53827471 |
| 28 | FRK | 1.52721510 |
| 29 | LATS2 | 1.50390002 |
| 30 | EPHA3 | 1.47776685 |
| 31 | ABL2 | 1.34698558 |
| 32 | PAK3 | 1.26712257 |
| 33 | EPHB1 | 1.24988528 |
| 34 | PDGFRB | 1.24406255 |
| 35 | MET | 1.23196654 |
| 36 | PTK2B | 1.21863210 |
| 37 | FER | 1.20824371 |
| 38 | MAPKAPK2 | 1.18681465 |
| 39 | ARAF | 1.17360294 |
| 40 | NEK9 | 1.08932041 |
| 41 | JAK1 | 1.04686891 |
| 42 | PIK3CG | 1.04370580 |
| 43 | LIMK1 | 1.03180880 |
| 44 | PTK2 | 1.02277716 |
| 45 | CAMK1D | 1.01962951 |
| 46 | JAK3 | 0.96826891 |
| 47 | MAP3K11 | 0.95838073 |
| 48 | DAPK3 | 0.93705491 |
| 49 | ERBB4 | 0.93343775 |
| 50 | PIK3CA | 0.93301199 |
| 51 | FLT3 | 0.93141461 |
| 52 | MAPKAPK3 | 0.90586096 |
| 53 | RPS6KA2 | 0.86390737 |
| 54 | MAP2K1 | 0.84653138 |
| 55 | TYK2 | 0.84642987 |
| 56 | ROCK1 | 0.79921526 |
| 57 | TNK2 | 0.79849111 |
| 58 | RET | 0.79300854 |
| 59 | NLK | 0.77624166 |
| 60 | LRRK2 | 0.73871809 |
| 61 | TRPM7 | 0.72384164 |
| 62 | MAP3K7 | 0.70674711 |
| 63 | PRKD1 | 0.70563470 |
| 64 | BMX | 0.67320675 |
| 65 | MST1R | 0.66216318 |
| 66 | CDC42BPA | 0.66172399 |
| 67 | RPS6KL1 | 0.64991901 |
| 68 | RPS6KC1 | 0.64991901 |
| 69 | LMTK2 | 0.64439783 |
| 70 | DAPK2 | 0.63871827 |
| 71 | STK3 | 0.62853807 |
| 72 | CAMK1G | 0.62465270 |
| 73 | STK10 | 0.62355733 |
| 74 | MAP2K3 | 0.62040967 |
| 75 | MTOR | 0.61595756 |
| 76 | PRKCH | 0.61255579 |
| 77 | MAPK7 | 0.60786186 |
| 78 | FGFR3 | 0.60314354 |
| 79 | FGFR1 | 0.59584063 |
| 80 | MAPK11 | 0.58697247 |
| 81 | ROCK2 | 0.58274317 |
| 82 | PRKAA2 | 0.58070849 |
| 83 | INSR | 0.57322533 |
| 84 | NTRK1 | 0.57012842 |
| 85 | GRK6 | 0.56952153 |
| 86 | STK38L | 0.56138584 |
| 87 | MAPK12 | 0.55417451 |
| 88 | CDK8 | 0.55172827 |
| 89 | JAK2 | 0.55081378 |
| 90 | CDK6 | 0.53598958 |
| 91 | GSK3A | 0.53056736 |
| 92 | PDK3 | 0.52725722 |
| 93 | PDK4 | 0.52725722 |
| 94 | ICK | 0.51228621 |
| 95 | IGF1R | 0.51081471 |
| 96 | GRK1 | 0.51076004 |
| 97 | CLK1 | 0.49365587 |
| 98 | ZAP70 | 0.49017886 |
| 99 | RPS6KA6 | 0.48707159 |
| 100 | STK38 | 0.47833055 |
| 101 | TGFBR1 | 0.47385952 |
| 102 | TAOK2 | 0.45870139 |
| 103 | MAP3K10 | 0.45801055 |
| 104 | MAP3K6 | 0.44982303 |
| 105 | CAMK4 | 0.44351894 |
| 106 | MAPK3 | 0.44094926 |
| 107 | PAK4 | 0.43460914 |
| 108 | PHKG2 | 0.43378358 |
| 109 | PHKG1 | 0.43378358 |
| 110 | PDK2 | 0.43184511 |
| 111 | PRKCE | 0.41427711 |
| 112 | ERBB2 | 0.41403029 |
| 113 | MAP2K4 | 0.40883208 |
| 114 | ADRBK1 | 0.40379001 |
| 115 | MAP3K1 | 0.40320803 |
| 116 | PRKACB | 0.40253632 |
| 117 | PAK1 | 0.39954037 |
| 118 | MAP2K2 | 0.39365218 |
| 119 | PRKG2 | 0.38512882 |
| 120 | PRKCD | 0.38368042 |
| 121 | SRC | 0.38342331 |
| 122 | ILK | 0.38305339 |
| 123 | MAPK1 | 0.37821305 |
| 124 | PDPK1 | 0.37408079 |
| 125 | OBSCN | 0.37261191 |
| 126 | EIF2AK2 | 0.36988389 |
| 127 | PRKD2 | 0.36838035 |
| 128 | MAP3K3 | 0.36832235 |
| 129 | CAMK2G | 0.36199271 |
| 130 | PRPF4B | 0.35878522 |
| 131 | PIM2 | 0.35727776 |
| 132 | CAMK2D | 0.35002178 |
| 133 | RPS6KA4 | 0.33754940 |
| 134 | CDK3 | 0.33549139 |
| 135 | NUAK1 | 0.33405976 |
| 136 | PKN1 | 0.33361303 |
| 137 | DYRK1B | 0.31744310 |
| 138 | MAPK15 | 0.30530974 |
| 139 | ABL1 | 0.29500250 |
| 140 | CSK | 0.29361550 |
| 141 | MARK2 | 0.28563453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.81727058 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20397317 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18347804 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.92439272 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.72709686 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70079797 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61086288 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60298313 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37985687 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36254250 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.27484917 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15784216 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.07804882 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04943035 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97350440 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.96452517 |
| 17 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.95804917 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93362754 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.77173084 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74345386 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.70390264 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.70319894 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.67267385 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.66474567 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.61995972 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.58272167 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52050907 |
| 28 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.51848315 |
| 29 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.50727409 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50325334 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44574606 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42908273 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.35065242 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31332787 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24305506 |
| 36 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21304902 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20537208 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20513711 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19552894 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12433058 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.11369673 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10869113 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 1.10613734 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.09836238 |
| 45 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.07449413 |
| 46 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03240700 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02689401 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01446560 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01118473 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.00378919 |
| 51 | Lysine degradation_Homo sapiens_hsa00310 | 0.99488412 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97540446 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96980709 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96619674 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95921245 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.95332969 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93887167 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91785466 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.87817678 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.86406238 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.76584024 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.74388476 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71575023 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.70969721 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.68366822 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65722564 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.65676596 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64982298 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63941505 |
| 70 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61831951 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60941882 |
| 72 | Adherens junction_Homo sapiens_hsa04520 | 0.60197165 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56131832 |
| 74 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.55324991 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.55099608 |
| 76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54867232 |
| 77 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54428667 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53938326 |
| 79 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53856101 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53365357 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52992884 |
| 82 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52928552 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52480464 |
| 84 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52250530 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51395051 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51124117 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49742418 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49233250 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.48966096 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47878816 |
| 91 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47583799 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.47298372 |
| 93 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47013345 |
| 94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.46872328 |
| 95 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46548896 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.45676365 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43160788 |
| 98 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43016227 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.42241585 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42114942 |
| 101 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41826933 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39856368 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39738847 |
| 104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38070660 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37664749 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37468690 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.37173715 |
| 108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36973184 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36575570 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.35984124 |
| 111 | Platelet activation_Homo sapiens_hsa04611 | 0.35038112 |
| 112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34052237 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33513108 |
| 114 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.31511001 |
| 115 | Melanoma_Homo sapiens_hsa05218 | 0.31262727 |
| 116 | Phagosome_Homo sapiens_hsa04145 | 0.31051454 |
| 117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30387111 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29758924 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.28817932 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.28565680 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28565537 |
| 122 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28118782 |
| 123 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26737150 |
| 124 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26083955 |
| 125 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.25967454 |
| 126 | Apoptosis_Homo sapiens_hsa04210 | 0.24994780 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23560320 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.23380714 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.22629162 |
| 130 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.22373419 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.21369377 |
| 132 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.20857591 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20605886 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19039666 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.18157342 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.17197000 |
| 137 | Mineral absorption_Homo sapiens_hsa04978 | 0.16769505 |
| 138 | Prostate cancer_Homo sapiens_hsa05215 | 0.16326950 |
| 139 | Glioma_Homo sapiens_hsa05214 | 0.16252602 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.16172324 |
| 141 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16155711 |
| 142 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.15827121 |
| 143 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15265315 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.15234562 |
| 145 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.15169385 |
| 146 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.14982536 |
| 147 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.14046421 |
| 148 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.13570063 |

